Abbott Vascular
3200 Lakeside Dr.
Santa Clara, CA 95054
USA
Phone:
(408) 845-3000
Product Categories:
Related Content
News | October 29, 2013
Biotronik Japan announced enrollment of the first patient in the Bioflow-IV ...
Videos | Heart Valve Technology | October 25, 2013
This animation, provided by Abbott Vascular, demonstrates how the U.S.
Technology | October 25, 2013
The U.S. Food and Drug Administration (FDA) has granted market clearance for the MitraClip, the first minimally...
News | October 23, 2013
October 23, 2013 — Vascular Interventional Advances (VIVA) Physicians, a not-for-profit organization dedicated to...
Abbott Bioresorbable Vascular Scaffold
News | September 20, 2013
The Mount Sinai Medical Center is participating in the nationwide Absorb III clinical trial testing the performance and...
Feature | September 13, 2013 | Dave Fornell
Vascular closure devices have a definite niche in areas where they were not originally intended but have found frequent...
Feature | September 13, 2013 | Patrick Antoun, M.D., and Jeffrey A. Breall, M.D., Ph.D.
Vascular closure devices (VCD) were first introduced in the early 1990s with a goal to achieve quick hemostasis, thus...
News | September 12, 2013
Abbott promised preliminary results from a study presented at the ESC Congress 2013, suggesting that its high sensitive...
News | August 02, 2013
Abbott announced results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay. The study, conducted by...
Boston Scientific's Apex PTCA dilatation balloon catheter. In 2012, Boston Scientific was the market leader in the PTCA and cutting balloon market, with more than half of the market share.
Feature | July 23, 2013 | Kamran Zamanian, Ph.D., and Jefferson Harding, B.Sc., MA
Percutaneous transluminal coronary angioplasty (PTCA) balloon catheters were the first devices used in the field of...
